Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EuroAPI Treprostinil

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Treprostinil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 351,725Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Liquidia schedules first Yutrepia shipment for PAH and PH-ILD
    Liquidia schedules first Yutrepia shipment for PAH and PH-ILD

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091683/0/en/Liquidia-Schedules-First-Commercial-Shipment-of-YUTREPIA-treprostinil-Inhalation-Powder-for-Patients-with-PAH-and-PH-ILD.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Corsair Pharma Completes Preclinical Program for Treprostinil Prodrug
    Corsair Pharma Completes Preclinical Program for Treprostinil Prodrug

    17 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250312111736/en/Corsair-Pharma-Announces-Successful-Completion-of-Preclinical-Program-for-Its-Treprostinil-Prodrug-Transdermal-System

    BUSINESSWIRE
    17 Mar 2025
    Share Share
    United Therapeutics Completes Enrollment for Treprostinil Study
    United Therapeutics Completes Enrollment for Treprostinil Study

    04 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250204276953/en

    BUSINESSWIRE
    04 Feb 2025
    Share Share
    United Therapeutics to Feature Data at CHEST 2024 Meeting
    United Therapeutics to Feature Data at CHEST 2024 Meeting

    24 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240924167810/en

    BUSINESSWIRE
    24 Sep 2024
    Share Share
    Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
    Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity

    20 Aug 2024

    // BIOSPACE

    https://www.biospace.com/fda/liquida-misses-full-approval-for-pulmonary-hypertension-drug-as-competitor-retains-market-exclusivity

    BIOSPACE
    20 Aug 2024
    Share Share
    United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil
    United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil

    10 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240710696574/en

    BUSINESSWIRE
    10 Jul 2024
    Share Share